• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Bharat Biotech's Covaxin likely to get clearance from DCGI today

|
Google Oneindia News

New Delhi, Jun 22: Bharat Biotech's Covaxin is likely to get clearance from Drugs Controller General of India (DCGI) today, news agency ANI reported quoting Sources. Earlier, the agency had also reported that Hyderabad-based company submitted data from the Phase III clinical trials of its COVID vaccine to the drug regulator.

Bharat Biotechs Covaxin likely to get clearance from DCGI today

According to data from Phase III trials conducted on 25,800 participants across India, Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19.

Phase III data approval will likely also help Bharat Biotech secure an EUL (emergency use listing) from the World Health Organization.

Explained: The use of animal serum in making of vaccinesExplained: The use of animal serum in making of vaccines

This is the first made-in-India vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The meeting comes ahead of Bharat Biotech's 'pre-submission' meet with the WHO for the approval of the COVID vaccine.

Bharat Biotech's Covaxin is one of the three vaccines which are currently being used in India.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X